MARY SAJN: Open Payments
NPI 1477141729 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 19 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $343 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $120 |
| SCPHARMACEUTICALS INC. | 2 | $61 |
| Novo Nordisk Inc | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| PFIZER INC. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: REPATHA, FUROSCIX, Wegovy, VYNDAQEL, JARDIANCE, LOKELMA, AMVUTTRA, OPSUMIT.
Industry payments across IN — which companies pay providers there.
